An enhanced agreement between the two countries cements existing protections for pharma innovators and is being hailed by the ...

French drugmaker's Translate Bio unit accuses COVID rivals of infringing core lipid nanoparticle and mRNA purification ...

Regulation & Industry ...

Kevin Scott will lead the organisation representing in-house counsel in the UK, for companies such as AstraZeneca, Eli Lilly, ...

Separate lawsuits target Indian and Taiwanese pharma companies as Exelixis seeks to keep rival cabozantinib products off the ...

Leading women from the pharmaceutical and biotechnology sectors are among the more than 100 professionals recognised in a ...

China-headquartered Angelalign failed to convince UPC appellate judges to overturn a ban that affects its ability to offer ...

WilmerHale trade secrets expert moves to new firm ...

Pillsbury nabs ‘veteran’ IP litigator and trial lawyer from Goodwin ...

A high-profile hire will co-chair the firm's new office, bringing experience across biotech, therapeutics, genomics, diagnostics, and medical devices.

A Munich court ruled that Illumina infringed a rival’s DNA sequencing patents, handing the challenger an early victory in a dispute that is playing out across Europe and the US.

UPC revives patent, but timing sinks Guardant’s appeal ...